Status:
TERMINATED
Surpass Flow Diverter for Intracranial Aneurysms: SURMOUNT Registry Data Collection
Lead Sponsor:
Stryker Neurovascular
Conditions:
Cerebral Aneurysm
Eligibility:
All Genders
Brief Summary
The purpose of this observational post-marketing registry will be to collect and analyze safety, effectiveness, and quality of life outcomes, during and after treatment with the Surpass Flow Diverter....
Detailed Description
This will be a prospective, observational, multi-center, single-arm, post-marketing, international registry with consecutive enrollment of a minimum of 150 patients treated with the Surpass Flow Diver...
Eligibility Criteria
Inclusion
- Patients who are to be treated with a Surpass Flow Diverter(s) will be eligible to participate in this registry. Patients will be enrolled on a consecutive basis.
Exclusion
- This is a standard of care registry. Patients should be excluded if standard of care at a given site is such that they are not eligible for treatment with a Surpass Flow Diverter(s).
Key Trial Info
Start Date :
March 18 2015
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2019
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT02281721
Start Date
March 18 2015
End Date
December 1 2019
Last Update
July 14 2021
Active Locations (19)
Enter a location and click search to find clinical trials sorted by distance.
1
AZ groeninge
Kortrijk, Belgium, 8500
2
Helsinki University Hospital
Helsinki, Finland, 00260
3
Turun yliopistollinen keskussairaala
Turku, Finland, 20521
4
Hopital Jean Minjoz
Besançon, France, 25030